ZyCov-D: Zydus Cadila’s needle-free COVID-19 vaccination would cost Rs 1,128 per dose

According to the pricing breakdown provided by the firm, the three-dose needle-free COVID-19 vaccine from zydus Cadila would cost the Centre Rs 1,128. On November 8, the pharma company said that it had acquired a purchase order from the Union government to deliver one crore doses of ZyCoV-D at a cost of Rs 265 per dosage, excluding jet applicator and GST.

“Zydus Cadila has obtained an order from the Government of India to provide one crore doses of ZyCoV-D, the world’s first Plasmid DNA Vaccine, for Rs 265 per dosage and the needle-free applicator at Rs 93 per dose, excluding GST,” the pharma business said in a regulatory filing.

According to the price break up, a single dose of the vaccine will be made available to the Centre at Rs 376 which includes the cost of the jet applicator and GST, taking the price of 3-dose jab to Rs 1,128.

The vaccine maker said that the pricing has been decided in consultation with the Centre.

The vaccine will be administered using a needle-free applicator, called PharmaJet, instead of traditional syringes.

The PharmaJet is a needle-free applicator to ensure painless intradermal vaccine delivery which also leads to a significant reduction in any kind of major side effects.

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the COVID-19 virus, Zydus Cadila said.

The firm said that ZyCov-D has shown good stability at temperatures of around 25 degrees for at least three months.

ZyCoV-D is the first vaccine cleared by India’s drug regulator for inoculation of those aged 12 years and above.

The three doses of ZyCoV-D, are to be administered 28 days apart. The vaccine was given emergency use authorization (EUA) by the Indian drug regulator on August 20.

Medically Speaking

Recent Posts

One Sleepless Night Can Weaken Your Immunity and Trigger Inflammation

Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…

2 days ago

Thick Heart Syndrome: A Silent Threat to Millions in India

Heart disease remains one of the leading causes of death worldwide, and in India, cardiovascular…

2 days ago

Delhi Sees Surge in H1N1 and Influenza B Cases

Delhi is witnessing a sharp rise in flu cases, particularly Influenza B and H1N1 (commonly…

2 days ago

Woman Dies During MRI Scan Due to Medical Negligence

In early February 2025, a tragic incident occurred in Eluru, Andhra Pradesh, where a 61-year-old…

2 days ago

Holi and Eye Safety: Protect Your Vision During Festivities

Holi, the festival of colors, is one of the most vibrant and joyous celebrations in…

3 days ago

FDA Recalls Popular Skincare Products Over Cancer-Causing Chemical

In a major development, the U.S. Food and Drug Administration (FDA) has issued recalls for…

3 days ago